🇺🇸 FDA
Patent

US 9375423

Use of aminoindane compounds in treating overactive bladder and interstitial cystitis

granted A61KA61K31/015A61K31/167

Quick answer

US patent 9375423 (Use of aminoindane compounds in treating overactive bladder and interstitial cystitis) held by Asana BioSciences, LLC expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Asana BioSciences, LLC
Grant date
Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/015, A61K31/167, A61K31/40, A61K31/435